ID

27854

Beschreibung

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01027065

Link

https://clinicaltrials.gov/show/NCT01027065

Stichworte

Versionen (1)
  1. 01.12.17 01.12.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

1. Dezember 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chronic Hepatitis B NCT01027065

Englisch

Eligibility Chronic Hepatitis B NCT01027065

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hbv-infected patients
Beschreibung

Hepatitis B, Chronic

Datentyp

boolean

Alias
UMLS CUI [1]
C0524909
hbeag-negative patients
Beschreibung

Hepatitis B e antigen negative

Datentyp

boolean

Alias
UMLS CUI [1]
C0948827
age > 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patients with active chronic hepatitis at the start of the antiviral treatment
Beschreibung

Hepatitis, Chronic | Antiviral Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0019189
UMLS CUI [2]
C0280274
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
Beschreibung

Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0369332
UMLS CUI [1,2]
C3827727
UMLS CUI [2,1]
C0971023
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0384228
UMLS CUI [3,2]
C0205360
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
Beschreibung

entecavir | Tenofovir | Pegylated interferon alfa Acceptable

Datentyp

boolean

Alias
UMLS CUI [1]
C0971023
UMLS CUI [2]
C0384228
UMLS CUI [3,1]
C0907160
UMLS CUI [3,2]
C1879533
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
infection by hcv
Beschreibung

Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1]
C0019196
infection by hiv-1 and /or hiv-2
Beschreibung

HIV-1 infection | HIV-2 infection

Datentyp

boolean

Alias
UMLS CUI [1]
C2363741
UMLS CUI [2]
C0854094
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
Beschreibung

Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0205369
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C1708385
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019163
previous treatment by lamivudine and/or nucleosides analogues
Beschreibung

Lamivudine | Nucleoside Analogs

Datentyp

boolean

Alias
UMLS CUI [1]
C0209738
UMLS CUI [2]
C1579410
inactive carrier
Beschreibung

Carrier Without Activity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0560175
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0205177
cirrhosis
Beschreibung

Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
other liver disease (notably from alcoholic, metabolic or immunological origin)
Beschreibung

Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0023896
UMLS CUI [3,1]
C0023895
UMLS CUI [3,2]
C0015127
UMLS CUI [3,3]
C0311400
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0015127
UMLS CUI [4,3]
C0205470
history of clinical autoimmune disease or active auto-immune disease
Beschreibung

Autoimmune Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0004364
type i diabetes mellitus
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
severe asthma, presently on chronic medications
Beschreibung

Severe asthma | Pharmaceutical Preparations chronic

Datentyp

boolean

Alias
UMLS CUI [1]
C0581126
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0205191
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Chronic Hepatitis B NCT01027065

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B, Chronic
Item
chronic hbv-infected patients
boolean
C0524909 (UMLS CUI [1])
Hepatitis B e antigen negative
Item
hbeag-negative patients
boolean
C0948827 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Hepatitis, Chronic | Antiviral Therapy
Item
patients with active chronic hepatitis at the start of the antiviral treatment
boolean
C0019189 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable
Item
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
boolean
C0369332 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0384228 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
entecavir | Tenofovir | Pegylated interferon alfa Acceptable
Item
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
boolean
C0971023 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0907160 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C
Item
infection by hcv
boolean
C0019196 (UMLS CUI [1])
HIV-1 infection | HIV-2 infection
Item
infection by hiv-1 and /or hiv-2
boolean
C2363741 (UMLS CUI [1])
C0854094 (UMLS CUI [2])
Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B
Item
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
Lamivudine | Nucleoside Analogs
Item
previous treatment by lamivudine and/or nucleosides analogues
boolean
C0209738 (UMLS CUI [1])
C1579410 (UMLS CUI [2])
Carrier Without Activity
Item
inactive carrier
boolean
C0560175 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological
Item
other liver disease (notably from alcoholic, metabolic or immunological origin)
boolean
C0023895 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0023896 (UMLS CUI [2])
C0023895 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0311400 (UMLS CUI [3,3])
C0023895 (UMLS CUI [4,1])
C0015127 (UMLS CUI [4,2])
C0205470 (UMLS CUI [4,3])
Autoimmune Disease
Item
history of clinical autoimmune disease or active auto-immune disease
boolean
C0004364 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Severe asthma | Pharmaceutical Preparations chronic
Item
severe asthma, presently on chronic medications
boolean
C0581126 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video